Resource type: Original research — laboratory and tumour-tissue study
Publication
Savannah Luu; Cynthia Bell; Sarah Schneider; Thu Annelise Nguyen (2019). Connexin 26 and Connexin 43 in Canine Mammary Carcinoma. Veterinary Sciences, 6(4), article 101. DOI: 10.3390/vetsci6040101
Published online: 9 December 2019.
Reading note: The study examines connexin expression and intercellular communication. Its discussion of possible future therapeutics is not evidence of an established treatment.
Author abstract
The following is the authors’ abstract, not a site-written summary. Wording is retained; paragraph structure and inline typography are formatted for this page.
Incidence of canine mammary carcinoma is two times higher than the rate of human breast cancer. Mammary tumors are the most common type of cancer in intact female dogs and account for about half of all neoplasms in these dogs. Well-established models of breast cancer have shown that neoplastic cells often have a loss of intercellular communication, particularly gap junction proteins. Thus, the objective of this study is to explore the aspect of gap junction intercellular communication in canine mammary carcinoma, non-cancerous (CMEC) and cancerous (CMT12, CMT27, and CF41.Mg) cells, and patient-derived tumors. Both non-cancerous and cancerous mammary cells express connexins 26 and 43 using immunofluorescence; however, the level of expression is significantly different in quantitative analysis using western blot in which connexin 43 in both CMT12 and CMT27 is significantly decreased compared to CMEC. Furthermore, a decrease of gap junction capacity in CMT12 and CMT27 was observed compared to CMEC. Immunostaining of CMT27-xenograft tumors revealed positive Cx26 and negative Cx43 expression. Similarly, immunostaining of spontaneous canine mammary tumors revealed that Cx26 is present in all tumors while Cx43 is present in 25% of tumors. Overall, the study provides for the first time that a differential pattern of connexin expression exists between non-cancerous and cancerous mammary cells in dogs. This study will pave the path for further in vitro work of connexins in comparative canine models and possibly allow for novel therapeutics to be developed.
Source and attribution
© 2019 by the authors. Reused under Creative Commons Attribution 4.0 (CC BY 4.0). The researchers named above are the publication authors; this site provides the resource presentation.
Read the original publication · Read the repository copy (Europe PMC)
Presentation changes: bibliographic and resource-type labels added; import formatting cleaned. Author-abstract wording is preserved. Existing images, source URLs and attachments are retained; separately credited material remains subject to its own terms.
Existing publication image
